KRAS and TP53 status as a predictor of survival in patients with resected pancreatic ductal adenocarcinoma Meeting Abstract


Authors: McIntyre, C. A.; Lawrence, S. A.; Wong, W.; Chou, J. F.; Capanu, M.; Berger, M. F.; Allen, P.; O'Reilly, E. M.
Abstract Title: KRAS and TP53 status as a predictor of survival in patients with resected pancreatic ductal adenocarcinoma
Meeting Title: 2019 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 4 Suppl.
Meeting Dates: 2019 Jan 17-19
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-02-01
Language: English
ACCESSION: WOS:000489107600308
DOI: 10.1200/JCO.2019.37.4_suppl.276
PROVIDER: wos
Notes: Meeting Abstract: 276 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joanne Fu-Lou Chou
    332 Chou
  2. Marinela Capanu
    386 Capanu
  3. Peter Allen
    501 Allen
  4. Eileen O'Reilly
    784 O'Reilly
  5. Michael Forman Berger
    766 Berger
  6. Winston Wong
    29 Wong